MaRS Innovation partners on Triphase oncology development accelerator.

MaRS Innovation, a Canada-based commercialisation firm working with several universities in the Toronto area, has partnered with the Fight Against Cancer Innovation Trust (FACIT) to turn the Triphase Accelerator Corporation into an oncology development accelerator. Triphase, an Ontario Institute for Cancer Research, was originally formed in 2010 by MaRS and FACIT to be a cancer-focused…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.